PEN – Penumbra, Inc.

Penumbra, Inc.

PEN

$310.91

Name : Penumbra, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $12,175,911,936.00

EPSttm : 4.2

Penumbra, Inc.

$310.91

1.07%

$3.36

Float Short %

4.24

Margin Of Safety %

-20

Put/Call OI Ratio

0.29

EPS Next Q Diff

0.12

EPS Last/This Y

3.41

EPS This/Next Y

1.25

Price

310.94

Target Price

338.44

Analyst Recom

1.43

Performance Q

24.55

Relative Volume

0.46

Beta

0.72

Ticker: PEN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-02	PEN	287.62	0.26	0.00	3445
2025-12-03	PEN	285.71	0.26	0.00	3445
2025-12-04	PEN	294.71	0.26	0.17	3450
2025-12-05	PEN	300.67	0.26	0.00	3527
2025-12-08	PEN	294.85	0.26	0.11	3501
2025-12-09	PEN	287.18	0.25	0.03	3808
2025-12-10	PEN	303.19	0.25	0.16	3806
2025-12-11	PEN	311.51	0.25	0.46	3803
2025-12-12	PEN	311.92	0.25	0.02	3841
2025-12-15	PEN	309.27	0.25	0.59	3845
2025-12-16	PEN	307.7	0.26	0.00	3880
2025-12-17	PEN	309.26	0.25	0.10	3941
2025-12-18	PEN	315.17	0.25	0.01	3996
2025-12-19	PEN	315.92	0.25	0.05	4055
2025-12-22	PEN	320.64	0.30	0.17	2122
2025-12-23	PEN	316.11	0.30	0.32	2169
2025-12-26	PEN	316.99	0.31	0.23	2195
2025-12-29	PEN	314.91	0.30	4.33	2237
2025-12-30	PEN	314.48	0.31	0.00	2251
2025-12-31	PEN	311.03	0.29	0.06	2356
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-02	PEN	287.71	12.6	52.1	3.76
2025-12-03	PEN	285.71	12.6	53.7	3.76
2025-12-04	PEN	294.72	12.6	63.3	3.76
2025-12-05	PEN	300.66	12.6	60.4	3.76
2025-12-08	PEN	294.83	12.4	-	3.76
2025-12-09	PEN	287.14	12.4	49.0	3.76
2025-12-10	PEN	302.98	12.4	69.2	3.76
2025-12-11	PEN	311.26	12.4	62.1	3.76
2025-12-12	PEN	311.92	12.4	55.9	3.76
2025-12-15	PEN	309.15	12.4	53.2	3.76
2025-12-16	PEN	309.15	12.4	54.4	3.76
2025-12-17	PEN	309.18	12.4	56.3	3.76
2025-12-18	PEN	315.40	12.4	60.4	3.76
2025-12-19	PEN	315.97	12.4	55.9	3.76
2025-12-22	PEN	319.34	12.9	58.4	3.77
2025-12-23	PEN	316.31	12.9	52.2	3.77
2025-12-26	PEN	317.20	12.9	56.5	3.77
2025-12-29	PEN	315.03	12.9	53.9	3.77
2025-12-30	PEN	314.36	12.9	55.0	3.77
2025-12-31	PEN	310.94	12.9	52.8	3.77
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-02	PEN	-10.69	2.52	4.45
2025-12-03	PEN	-10.69	2.52	4.45
2025-12-04	PEN	-10.74	2.52	4.45
2025-12-05	PEN	-10.70	2.52	4.45
2025-12-08	PEN	-10.70	2.54	4.45
2025-12-09	PEN	-10.70	2.54	4.45
2025-12-10	PEN	-10.72	2.54	3.99
2025-12-11	PEN	-10.72	2.54	3.99
2025-12-12	PEN	-10.72	2.54	3.99
2025-12-15	PEN	-9.68	2.54	3.99
2025-12-16	PEN	-10.69	2.54	3.99
2025-12-17	PEN	-10.69	2.54	3.99
2025-12-18	PEN	-10.69	2.54	3.99
2025-12-19	PEN	-10.69	2.54	3.99
2025-12-22	PEN	-10.69	2.54	3.99
2025-12-23	PEN	-10.84	2.54	3.99
2025-12-26	PEN	-10.84	2.54	4.24
2025-12-29	PEN	-9.78	2.54	4.24
2025-12-30	PEN	-9.78	2.54	4.24
2025-12-31	PEN	-9.78	2.54	4.24
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

1.09

Avg. EPS Est. Next Quarter

1.09

Insider Transactions

-9.78

Institutional Transactions

2.54

Beta

0.72

Average Sales Estimate Current Quarter

361

Average Sales Estimate Next Quarter

369

Fair Value

250.03

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

10.8

Max Drawdown 5-Year %

-62.6

Target Price

338.44

P/E

74.3

Forward P/E

61.53

PEG

1.44

P/S

9.13

P/B

8.96

P/Free Cash Flow

79.78

EPS

4.18

Average EPS Est. Cur. Y

3.77

EPS Next Y. (Est.)

5.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.3

Relative Volume

0.46

Return on Equity vs Sector %

-15.2

Return on Equity vs Industry %

-5.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

52.8

Penumbra, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 4500

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

stock quote shares PEN – Penumbra, Inc. Stock Price stock today

news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PEN – Penumbra, Inc. yahoo finance google finance

stock history PEN – Penumbra, Inc. invest stock market

stock prices PEN premarket after hours

ticker PEN fair value insiders trading

PEN – Penumbra, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y